Therapies versus placebo in the treatment of patchy alopecia areata

J Am Acad Dermatol. 1986 Aug;15(2 Pt 1):209-10. doi: 10.1016/s0190-9622(86)70158-8.

Abstract

We report the results of a controlled trial on 119 patients affected by patchy alopecia areata involving less than 40% of the scalp. The statistical analysis showed no differences between the results obtained using squaric acid dibutylester, diphencyprone, minoxidil, and placebo in the treatment of this form of alopecia.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Alopecia Areata / drug therapy*
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Cyclobutanes / therapeutic use
  • Cyclopropanes / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Minoxidil / therapeutic use
  • Placebos

Substances

  • Cyclobutanes
  • Cyclopropanes
  • Placebos
  • squaric acid dibutyl ester
  • Minoxidil
  • diphenylcyclopropenone